Drug intelligence / Profile preview

platelet-rich fibrin (University Hospital, Strasbourg)

Development stage
Preclinical
Lead developer
Strasbourg University Hospital
Modality
Cell Therapies
Administration
Topical, Surgical Implant
01

Overview

Platelet-rich fibrin (PRF) is an autologous biologic material derived from a patient's own blood, consisting of a fibrin matrix enriched with platelets, leukocytes, and various growth factors. In research conducted at the University Hospital, Strasbourg, PRF is being investigated as a biological coating to functionalize prosthetic patches, such as expanded polytetrafluoroethylene (e-PTFE), used in the surgical repair of congenital diaphragmatic hernia (CDH). The PRF coating, often applied in conjunction with polydopamine (PDA), is intended to improve the biocompatibility of synthetic materials, promoting cellular colonization and tissue integration to reduce the risk of prosthesis release and recurrence in neonatal patients. The research specifically evaluates the efficacy of PRF derived from neonates with CDH compared to healthy adults in promoting cell colonization on hydrophobic prosthetic surfaces.

Other names
PRFPlatelet-Rich Fibrin

Beyond the preview

Go deeper on platelet-rich fibrin (University Hospital, Strasbourg).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on platelet-rich fibrin (University Hospital, Strasbourg).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call